Biogen, Molson Coors, Krispy Kreme: Trending tickers
Biogen (BIIB) shares are falling after the company reported lower revenue and profit in its fourth quarter results, missing analyst estimates.
Molson Coors (TAP) returned to profitability in fourth-quarter results, reporting earnings of $0.48 per share compared to loss the previous year. The company was able to gain market share in 2023, helping to give a boost to profits.
Krispy Kreme (DNUT) shares slipped early Tuesday after the company missed on fourth-quarter profit expectations and provided disappointing forward guidance for 2024.
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Editor's note: This article was written by Angel Smith
Video Transcript
- We are about 31 minutes into today's trading activity. Let's take a look at how things are shaping up. Stocks are in the red, sliding away from recent highs as investors digest the hotter than expected January inflation report.
- That's right. And also taking a look at some individual trending tickers. Shares of Biogen under pressure this morning. That's after reporting lower revenue and profits in its fourth quarter compared to a year ago. The pharmaceutical company seeing sales slump in its biggest drug category, multiple sclerosis therapies.
- And Molson Coors shares under pressure this morning despite a swing back to profitability in the company's fourth quarter. The beer cellar saw earnings of $0.48 per share compared to a loss of $2.63 a share a year ago. Boosted by higher sales as the company gained market share in 2023, amid boycotts against Bud Light.
- And shares of Krispy Kreme slipping after missing expectations for profit in its fourth quarter and offering guidance that lagged consensus estimates. Shares of the donut maker currently off, as you can see they're just about almost 7% on the day.
